With 6.50M Outstanding Shares, Can Applied Dna Sciences Inc (NASDAQ: APDN) Deliver Big Short-Term Gains?

Applied Dna Sciences Inc (NASDAQ:APDN) currently has a daily average trading volume of 1.34M but it saw 2038552 shares traded in last market. With a market cap of 3.57M USD, the company’s current market price of $0.55 came falling about -5.27 while comparing to the previous closing price of $0.58. In past 52 weeks, the stock remained buoying in the range of price level as high as $177.00 and as low as $0.56.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the ROTH Capital which initiated the stock as “Buy” in its note to investors issued on February 12, 2021, recommending a price target of $24 for it. H.C. Wainwright issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $20 and $12.

Over the week, APDN’s stock price is moving -32.14% down while it is -36.36% when we observe its performance for the past one month. Year-to-date it is -94.61% down and over the past year, the stock is showing a downside performance of -99.44%.

Currently, Applied Dna Sciences Inc’s total number of outstanding shares is 6.50M with 3.31% of that held by the insiders while 4.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -441.56% and return on equity (ROE) at -141.39%. Stock’s beta reads 0.18. Stock has a price to book (P/B) ratio of 0.33 while price to sale or P/S ratio amounts to 0.94. Its return on asset (ROA) is -66.28% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.